View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
March 30, 2022

eClinicalHealth creates digitised SAPASI version for trial researchers

Patients can indicate where their psoriasis is present on the digital map which uses the SAPASI diagnostic tool.

eClinicalHealth has created a digitised form of the SAPASI instrument, enabling researchers in monitoring and recording moderate-to-severe plaque psoriasis in patients enrolled in the clinical trials.

The digitised version was developed by the company in partnership with the Department of Dermatology at Wake Forest University School of Medicine in the US.

This novel SAPASI ePRO tool, which is part of eClinicalHealth’s decentralised clinical trial (DCT) research platform Clinpal, aids patients on any device to indicate where their psoriasis is present on a digital body map at time intervals mentioned under the protocol.

It also aids in answering various prompts linked to psoriasis lesion severity. 

This information is incorporated into a data model that researchers could use and track the effectiveness of a therapy.

The digital map uses the Self-administered Psoriasis Area Severity Index (SAPASI), an established diagnostic tool of Wake Forest.

The library of ePRO tools was expanded with the implementation of SAPASI on the Clinpal platform.

Clinpal platform offers a rapid trial set-up, a subject-friendly design and automatically computes the SAPSI score using an in-built compliance reminder mechanism to guarantee precise data delivery. 

Furthermore, it integrates seamlessly into the current Clinpal app without needing custom development.

The company noted that the digital map feature, part of the Capture module of the Clinpal platform, is one among the seven modules that constitute the complete DCT platform. 

Each module targets a vital role in trials, such as subject recruitment, successful self-registration and pre-screening expertise, intentional communication to eliminate subject noncompliance before trial commencement and ePRO tools, such as the latest digital SAPASI instrument.

eClinicalHealth CEO and board chairman Karl Landert said: “We’re excited about this evolution of our ePRO tools and pushing the Clinpal platform into new areas. 

“The new normal world has revealed the benefits of a telemedicine ecosystem for end-users. As DCTs gain traction, our aim is to further scale and simplify patient engagement.”

In September last year, eClinicalHealth and Larsen & Toubro Infotech entered a strategic collaboration for decentralising clinical trials for quicker outcomes.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Clinical Trials Arena